Bill Text: IA SF296 | 2021-2022 | 89th General Assembly | Enrolled
Bill Title: A bill for an act relating to the practice of pharmacy, including the prescription and administration of vaccines and collaborative pharmacy practice. (Formerly SSB 1095.) Effective date: 07/01/2021.
Spectrum: Committee Bill
Status: (Passed) 2021-05-19 - Signed by Governor. S.J. 1140. [SF296 Detail]
Download: Iowa-2021-SF296-Enrolled.html
Senate
File
296
-
Enrolled
Senate
File
296
AN
ACT
RELATING
TO
THE
PRACTICE
OF
PHARMACY,
INCLUDING
THE
PRESCRIPTION
AND
ADMINISTRATION
OF
VACCINES
AND
COLLABORATIVE
PHARMACY
PRACTICE.
BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
Section
1.
Section
155A.46,
subsection
1,
paragraph
a,
Code
2021,
is
amended
by
adding
the
following
new
subparagraph:
NEW
SUBPARAGRAPH
.
(7)
An
immunization
or
vaccination
for
C0VID-19
as
defined
in
section
686D.2.
Sec.
2.
Section
155A.46,
subsection
1,
Code
2021,
is
amended
by
adding
the
following
new
paragraph:
NEW
PARAGRAPH
.
e.
A
pharmacist
may,
pursuant
to
statewide
protocols
developed
by
the
board
in
consultation
with
the
Senate
File
296,
p.
2
department
of
public
health
and
consistent
with
subsection
2,
order
and
administer
the
following
to
patients
ages
six
years
and
older:
(1)
Point-of-care
testing
and
treatment
for
influenza,
streptococcus
A,
and
COVID-19
as
defined
in
section
686D.2
at
the
point
of
interaction
between
a
pharmacist
and
a
patient.
(2)
Point-of-care
testing
at
the
point
of
interaction
between
a
pharmacist
and
a
patient
in
response
to
a
public
health
emergency.
Sec.
3.
NEW
SECTION
.
155A.47
Collaborative
pharmacy
practice
——
agreements
——
payment.
1.
For
the
purposes
of
this
section:
a.
“Collaborative
pharmacy
practice”
means
a
practice
of
pharmacy
whereby
a
pharmacist
provides
patient
care
and
drug
therapy
management
services
not
otherwise
permitted
to
be
performed
by
a
pharmacist
to
patients
under
a
collaborative
pharmacy
practice
agreement
with
another
pharmacist
or
practitioner
which
defines
the
nature,
scope,
conditions,
and
limitations
of
the
patient
care
and
drug
therapy
management
services
to
be
provided
by
a
pharmacist
in
order
to
ensure
that
a
patient
achieves
the
desired
outcomes.
b.
“Health
benefit
plan”
means
the
same
as
defined
in
section
514J.102.
c.
“Health
carrier”
means
the
same
as
defined
in
section
514J.102.
2.
Notwithstanding
any
provision
of
law
to
the
contrary,
a
pharmacist
may
engage
in
a
collaborative
pharmacy
practice,
in
accordance
with
rules
adopted
by
the
board
pursuant
to
chapter
17A
and
under
a
collaborative
pharmacy
practice
agreement,
to
provide
patient
care
and
drug
therapy
management
services
to
a
patient.
3.
Notwithstanding
any
provision
of
a
health
benefit
plan
to
the
contrary,
whenever
a
health
benefit
plan
provides
for
payment
or
reimbursement
for
a
service
that
is
within
the
lawful
scope
of
practice
of
a
practitioner
or
pharmacist
and
the
service
is
provided
by
a
pharmacist
pursuant
to
a
collaborative
pharmacy
practice
agreement
under
this
section,
Senate
File
296,
p.
3
the
health
carrier
may
provide
payment
or
reimbursement
for
the
service.
______________________________
JAKE
CHAPMAN
President
of
the
Senate
______________________________
PAT
GRASSLEY
Speaker
of
the
House
I
hereby
certify
that
this
bill
originated
in
the
Senate
and
is
known
as
Senate
File
296,
Eighty-ninth
General
Assembly.
______________________________
W.
CHARLES
SMITHSON
Secretary
of
the
Senate
Approved
_______________,
2021
______________________________
KIM
REYNOLDS
Governor